Literature DB >> 2877855

Sulphasalazine for rheumatoid arthritis. Studies on dose, acetylator phenotype and efficacy.

R S Amos, D E Bax, M S Greaves.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2877855     DOI: 10.2165/00003495-198600321-00012

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  6 in total

1.  Which component of sulphasalazine is active in rheumatoid arthritis?

Authors:  T Pullar; J A Hunter; H A Capell
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-25

2.  Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.

Authors:  V C Neumann; K A Grindulis; S Hubball; B McConkey; V Wright
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-15

3.  Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate.

Authors:  T Pullar; J A Hunter; H A Capell
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-15

4.  Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate.

Authors:  D E Bax; R S Amos
Journal:  Ann Rheum Dis       Date:  1985-03       Impact factor: 19.103

5.  Sulphasalazine in rheumatoid arthritis.

Authors:  B McConkey; R S Amos; S Durham; P J Forster; S Hubball; L Walsh
Journal:  Br Med J       Date:  1980-02-16

6.  Sulphasalazine for rheumatoid arthritis: relationship between dose, acetylator phenotype and response to treatment.

Authors:  D E Bax; M S Greaves; R S Amos
Journal:  Br J Rheumatol       Date:  1986-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.